Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Werner Poewe

Showing results (81-90 of 602) with videos related to

Pageof 61
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2006
Minimal clinically important change on the unified Parkinson's disease rating scaleAnette Schrag, Cristina Sampaio, Nicholas Counsell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 13, 2022
How Does Deep Brain Stimulation Change the Course of Parkinson's Disease?Philipp Mahlknecht, Thomas Foltynie, Patricia Limousin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 3, 2017
Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's diseasePhilipp Mahlknecht, Florian Krismer, Werner Poewe, et al.
Parkinsonism & Related Disorders|March 2, 2024
Longitudinal brain changes in Parkinson's disease with severe olfactory deficitKazuya Kawabata, Epifanio Bagarinao, Klaus Seppi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 7, 2006
Auditory startle reaction in primary blepharospasmJörg Müller, Martina Rinnerthaler, Werner Poewe, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 31, 2009
Supplement neuroimaging movement disordersWerner Poewe, Christoph Scherfler, Eduardor Tolosa, et al.
CNS Drugs|September 2, 2019
Apomorphine for Parkinson's Disease: Efficacy and Safety of Current and New FormulationsFederico Carbone, Atbin Djamshidian, Klaus Seppi, et al.
Neuro-Degenerative Diseases|March 7, 2008
The 8th International Conference on Alzheimer's and Parkinson's Diseases. PrefaceIsrael Hanin, Manfred Windisch, Werner Poewe, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 20, 2015
Plasma fasting cholesterol profiles and age at onset in Parkinson's diseasePhilipp Mahlknecht, Fabienne Sprenger, Klaus Seppi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 29, 2012
Trial designs used to study neuroprotective therapy in Parkinson's diseaseAnthony E Lang, Eldad Melamed, Werner Poewe, et al.
Pageof 61

Showing results (81-90 of 602) with videos related to

Sort By:
Pageof 61
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2006
Minimal clinically important change on the unified Parkinson's disease rating scaleAnette Schrag, Cristina Sampaio, Nicholas Counsell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 13, 2022
How Does Deep Brain Stimulation Change the Course of Parkinson's Disease?Philipp Mahlknecht, Thomas Foltynie, Patricia Limousin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 3, 2017
Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's diseasePhilipp Mahlknecht, Florian Krismer, Werner Poewe, et al.
Parkinsonism & Related Disorders|March 2, 2024
Longitudinal brain changes in Parkinson's disease with severe olfactory deficitKazuya Kawabata, Epifanio Bagarinao, Klaus Seppi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 7, 2006
Auditory startle reaction in primary blepharospasmJörg Müller, Martina Rinnerthaler, Werner Poewe, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 31, 2009
Supplement neuroimaging movement disordersWerner Poewe, Christoph Scherfler, Eduardor Tolosa, et al.
CNS Drugs|September 2, 2019
Apomorphine for Parkinson's Disease: Efficacy and Safety of Current and New FormulationsFederico Carbone, Atbin Djamshidian, Klaus Seppi, et al.
Neuro-Degenerative Diseases|March 7, 2008
The 8th International Conference on Alzheimer's and Parkinson's Diseases. PrefaceIsrael Hanin, Manfred Windisch, Werner Poewe, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 20, 2015
Plasma fasting cholesterol profiles and age at onset in Parkinson's diseasePhilipp Mahlknecht, Fabienne Sprenger, Klaus Seppi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 29, 2012
Trial designs used to study neuroprotective therapy in Parkinson's diseaseAnthony E Lang, Eldad Melamed, Werner Poewe, et al.
Pageof 61